Towards a new type-of HMG-COA reductase inhibitor
- 1 January 1990
- journal article
- research article
- Published by Elsevier in Tetrahedron
- Vol. 46 (19) , 6731-6740
- https://doi.org/10.1016/s0040-4020(01)87862-5
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Synthesis, SARs and therapeutic potential of HMG-CoA reductase inhibitorsTrends in Pharmacological Sciences, 1987
- New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase.Circulation, 1987
- Compactin (ML-236B) and related compounds as potential cholesterol-lowering agents that inhibit HMG-CoA reductaseJournal of Medicinal Chemistry, 1985
- The Low-Density Lipoprotein Pathway and its Relation to AtherosclerosisAnnual Review of Biochemistry, 1977
- Kinetic analysis of the individual reductive steps catalyzed by β-hydroxy-β-methylglutaryl-coenzyme A reductase obtained from yeastBiochemistry, 1976
- ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.The Journal of Antibiotics, 1976
- The stereochemistry of the reduction of mevaldic acid‐coenzyme A hemithioacetal by rat liver 3‐hydroxy‐3‐methylglutaryl coenzyme A reductaseFEBS Letters, 1972
- Stereospecificity of the Transfer of Hydrogen from Reduced Nicotinamide Adenine Dinucleotide Phosphate in Each of the Two Reductive Steps Catalyzed by β-Hydroxy-β-methylglutaryl Coenzyme A ReductasePublished by Elsevier ,1971
- A Probable Intermediate in the Enzymic Reduction of 3-Hydroxy-3-methylglutaryl Coenzyme AEuropean Journal of Biochemistry, 1970
- Regulation of 3-hydroxy-3-methylglutarate and mevalonate biosynthesis by rat liver homogenates. Effects of fasting, cholesterol feeding, and triton administrationBiochemistry, 1970